title: Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
authors.forename: B
authors.initials: B
authors.lastname: Hamouda
authors.forename: Z
authors.initials: Z
authors.lastname: Jamila
authors.forename: R
authors.initials: R
authors.lastname: Najet
authors.forename: T
authors.initials: T
authors.lastname: Slim
authors.forename: N
authors.initials: N
authors.lastname: Rafiaa
authors.forename: B
authors.initials: B
authors.lastname: Noureddine
authors.forename: E M
authors.initials: EM
authors.lastname: Ahmed
authors.forename: F
authors.initials: F
authors.lastname: Mohamed
authors.forename: K M
authors.initials: KM
authors.lastname: Ridha
authors.forename: L
authors.initials: L
authors.lastname: Abderrahman
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005145:Face / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D016896:Treatment Outcome; D014983:Xeroderma Pigmentosum / Q000150:complications*
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil